fludrocortisone

Trials studying fludrocortisone

• phase3A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)recruitingn=1,314
• phase1A Drug-Drug Interaction Study of Itraconazole and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-017)active not recruitingn=14
• phase2Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)recruitingn=220
• phase2A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)recruitingn=250
• phase3Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)recruitingn=1,310
• phase1A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)completedn=14
• phase1A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)active not recruitingn=6
• phase1A Study to Evaluate Opevesostat (MK-5684) in Male Participants With Moderate Hepatic Impairment (MK-5684-009)completedn=16